查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1891475

注射筆針市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032）

Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast, 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

注射筆針市場成長驅動因素

受需要注射治療的慢性病患者數量增加的推動，全球注射筆針市場持續快速成長。根據最新的產業數據，預計該市場規模將在2024年達到22.8億美元，2025年達到24.1億美元。預計2032年將進一步成長至38.9億美元，在預測期內維持7.0%的穩定複合年增長率。北美地區在2024年繼續保持領先市場地位，佔39.47%的顯著市場。這得歸功於其完善的基礎設施、注射給藥裝置的高滲透率以及各種先進註射筆針品牌的廣泛供應。

注射筆在需要定期注射的疾病（例如糖尿病、骨質疏鬆症和生長激素缺乏症）的患者自我治療中發揮著至關重要的作用。頻繁更換（通常每天或多次使用後）確保了市場需求的持續成長。對注射筆給藥解決方案日益增長的依賴性顯著推動了市場規模的擴大。 Ypsomed 報告稱，2023 年 UnoPen 和 YpsoPen 的需求量創下歷史新高，銷售量分別超過 1 億支和 1000 萬支，反映了全球注射筆藥物的消費趨勢。

市場趨勢

影響市場發展的關鍵趨勢是，業內企業越來越重視改善給藥系統。製造商正在推出改良型產品，以提高使用者的安全性、舒適性和易用性。例如，2022 年 9 月，諾和諾德公司推出了其 Tresiba 注射筆的仿製藥，提高了糖尿病患者的用藥便利性。此外，各公司正在擴大產品供應範圍。 2024年4月，MTD Medical Technology and Devices S.p.A. 在美國推出了非處方（OTC）的Droplet Micron胰島素筆針，透過線上藥局和零售通路擴大了消費者的購買管道。

成長因素

全球代謝和內分泌疾病的增加仍然是市場的主要驅動因素。截至2021年，20至79歲成年人中糖尿病盛行率為10.5%，預計2045年這一數字將增加46%，這將增強對胰島素筆和筆針的長期需求。骨質疏鬆症也是一個重要的驅動因素。預計到2023年，美國50至64歲女性的盛行率為13.1%，65歲及以上女性的盛行率為27.5%，將增加對注射療法的需求。市場參與者正在不斷擴大其產品組合以滿足這一需求。例如，2024年3月，MTD收購了Ypsomed的胰島素筆針和血糖監測業務，增強了其產品能力和全球影響力。

市場限制因子

儘管需求強勁，但仍存在一些阻礙市場成長的因素。胰島素筆針有註射部位反應的風險，例如脂肪增生、皮膚感染和過敏，這些反應通常是由於注射技術不佳造成的。醫護人員也面臨暴露風險。根據2023年的一項研究，中國有3.2%的護理師因針刺傷而感染B型肝炎病毒（HBV）。此外，口服藥物等替代療法的出現，也為注射給藥裝置市場帶來了競爭壓力。

細分市場概覽

2024年，由於糖尿病的高發生率和人們對針刺傷風險認識不足，標準胰島素筆針在產品類型細分市場中佔主導地位。同時，由於對安全功能的需求不斷增長，安全型胰島素筆針預計將實現最快成長。

依藥物類型劃分，胰島素市場將在2024年佔最大佔有率，這反映了全球糖尿病患者數量龐大。先進注射解決方案的出現，例如Civica與Ypsomed合作於2023年推出的低成本胰島素筆，將繼續推動市場成長。

依疾病類型劃分，糖尿病在2024年仍將是領先領域。新產品的獲批，例如諾和諾德的基礎胰島素Awiqli（Icodec），將於2024年獲批，這將進一步推動該領域的擴張。預計到 2022 年，全球肥胖率將達到八分之一，這將推動肥胖症治療領域強勁成長。

針頭尺寸正朝著更短、更安全的方向發展，4 毫米針頭預計將於 2024 年成為主流，因為它可以降低肌肉注射的風險。 6 毫米針頭預計將實現最快增長，因為它可以提高注射舒適度。

區域展望

2024 年，北美市場將繼續保持領先地位，估值達 9 億美元，這主要得益於 Embecta、Cardinal Health 和 Allison Medical 等領先製造商的推動。歐洲也蘊藏著巨大的潛力，這主要得益於糖尿病的高發生率，例如到2024年，英國的糖尿病患者將達到430萬例。亞太地區預計將實現最快的成長，這得益於先進注射療法的不斷湧現，例如賽諾菲計劃於2024年在印度推出Soliqua。拉丁美洲以及中東和非洲地區也展現出良好的發展前景，這也得益於糖尿病的高發生率，例如2021年巴西有1570萬成年人患有糖尿病。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

章節4：主要發現

  • 2024年主要國家和地區糖尿病盛行率
  • 2024年主要國家及地區肥胖盛行率
  • 主要產業趨勢（併購、合作等）
  • 新冠疫情對市場的影響

第五章：全球胰島素筆針市場分析、洞察與預測（2019-2032）

  • 依產品類型劃分的市場分析、洞察與預測
    • 標準胰島素筆針
    • 安全胰島素筆針
  • 依藥物類型劃分的市場分析、洞察與預測
    • 胰島素
    • GLP-1
    • 增長激素
    • 其他
  • 市場分析、洞察與預測 - 依疾病分類
    • 糖尿病
    • 肥胖症
    • 荷爾蒙缺乏症
    • 其他
  • 市場分析、洞察與預測 - 依針頭尺寸分類
    • 4 毫米
    • 5 毫米
    • 6 毫米
    • 8 毫米
    • 12 毫米
  • 市場分析、洞察與預測 - 依銷售管道分類
    • 醫院藥房
    • 零售藥房
    • 線上藥房
  • 市場分析、洞察與預測 - 依地區分類
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美注射筆針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲注射筆針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞半島
    • 歐洲其他地區

第八章：亞太地區注射筆針市場分析、洞察與預測（2019-2032）

  • 依國家/地區
    • 日本
    • 中國
    • 澳大利亞
    • 印度
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲注射筆針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲注射筆針市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 南非
    • 海灣合作委員會
    • 拉丁美洲其他地區

第十一章：競爭格局分析

  • 全球市佔率分析（2024）
  • 公司簡介
    • 諾和諾德公司
    • Embecta公司
    • 貝朗公司
    • 歐文·芒福德公司
    • BD公司
    • 康德樂公司
    • SOL-Millennium公司
    • 泰爾茂株式會社
    • MTD醫療技術與設備公司
    • UltiMed公司
    • Allison Medical公司
Product Code: FBI110437

Growth Factors of pen needles Market

The global pen needles market continues to expand rapidly, driven by the rising prevalence of chronic conditions requiring injectable therapies. According to recent industry data, the market was valued at USD 2.28 billion in 2024 and is projected to reach USD 2.41 billion in 2025, eventually climbing to USD 3.89 billion by 2032, reflecting a steady CAGR of 7.0% over the forecast period. North America remained the dominant regional market in 2024 with a significant 39.47% share, supported by strong infrastructure, high adoption of injectable drug delivery devices, and widespread availability of advanced pen needle brands.

Pen needles play an essential role in patient-administered therapies, particularly for diseases requiring regular injections, such as diabetes, osteoporosis, and growth hormone deficiencies. Their frequent replacement-often daily or after several uses-ensures continuous market demand. Increasing reliance on pen-based drug delivery solutions is a major contributor to the expanding market base. In 2023, Ypsomed reported record demand for UnoPen and YpsoPen, exceeding 100 million and 10 million units sold, respectively, reflecting global consumption patterns for pen-based injectables.

Market Trends

A key trend influencing market development is the growing focus on improved drug delivery systems by industry players. Manufacturers are launching enhanced products that improve user safety, comfort, and access. For example, in September 2022, Novo Nordisk A/S introduced a generic version of its Tresiba injection pen, increasing accessibility for diabetic patients. Additionally, companies are expanding product availability: in April 2024, MTD Medical Technology and Devices S.p.A. made its Droplet Micron pen needles available over-the-counter in the U.S., broadening consumer access through online pharmacies and retail channels.

Growth Factors

The rising global burden of metabolic and hormonal disorders remains the leading market driver. Diabetes prevalence reached 10.5% of adults aged 20-79 years in 2021, with figures projected to rise by 46% by 2045, reinforcing long-term demand for insulin pens and pen needles. Osteoporosis is also a major contributor: in 2023, 13.1% of U.S. women aged 50-64 and 27.5% of women aged 65+ were affected, elevating the need for injectable treatments. Market players continue to expand their portfolios to meet this demand. For example, in March 2024, MTD acquired Ypsomed's pen needle and blood glucose monitoring businesses, advancing its product capabilities and global reach.

Restraints

Despite strong demand trends, certain factors hinder market growth. Pen needles carry risks of site reactions such as lipohypertrophy, skin infections, and allergies, often triggered by poor injection techniques. Healthcare providers also face exposure risks: a study reported in 2023 indicated 3.2% of nurses in China experienced HBV infections linked to needlestick injuries. Additionally, availability of alternative therapies-such as oral medications-places competitive pressure on injectable delivery device markets.

Segmentation Overview

Standard pen needles dominated the product type segment in 2024, driven by high diabetes prevalence and lower awareness of needlestick hazards. Conversely, safety pen needles are expected to grow at the fastest pace due to rising demand for injury prevention features.

Among drug types, the insulin segment held the largest share in 2024, reflecting the substantial global diabetic population. The launch of advanced injectable solutions, such as affordable insulin pens introduced through the 2023 Civica-Ypsomed partnership, continues to propel the market.

Based on disease indication, diabetes remained the leading segment in 2024. New product approvals, such as Novo Nordisk's 2024 regulatory clearance for Awiqli basal insulin icodec, further support segment expansion. The obesity segment is also poised for strong growth, supported by global obesity levels estimated at one in eight people in 2022.

Needle sizes are shifting toward shorter, safer formats, with 4 mm needles dominating 2024 due to reduced intramuscular injection risks. The 6 mm category is expected to grow fastest, attributed to improved injection comfort.

Regional Outlook

North America led the market in 2024 with a valuation of USD 0.90 billion, attributed to major manufacturers such as Embecta, Cardinal Health, and Allison Medical. Europe also holds substantial potential, driven by high diabetes prevalence, including 4.3 million cases in the U.K. in 2024. Asia Pacific is expected to grow fastest due to rising launches of advanced injection therapies, such as Sanofi's 2024 introduction of Soliqua in India. Latin America and the Middle East & Africa show promising prospects due to high diabetes rates, including 15.7 million adults affected in Brazil in 2021.

Conclusion

With rising global prevalence of chronic diseases, advancements in drug delivery systems, and increasing accessibility of injectable therapies, the pen needles market is set for sustained expansion, reaching USD 3.89 billion by 2032.

Segmentation By Product Type

  • Standard Pen Needles
  • Safety Pen Needles

By Drug Type

  • Insulin
  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication

  • Diabetes
  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Japan
    • China
    • Australia
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • South Africa
    • GCC
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2024
  • 4.2. Prevalence of Obesity - by Key Countries/Regions, 2024
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Standard Pen Needles
    • 5.1.2. Safety Pen Needles
  • 5.2. Market Analysis, Insights and Forecast - By Drug Type
    • 5.2.1. Insulin
    • 5.2.2. GLP-1
    • 5.2.3. Growth Hormone
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.3.1. Diabetes
    • 5.3.2. Obesity
    • 5.3.3. Hormone Deficiency
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Needle Size
    • 5.4.1. 4 mm
    • 5.4.2. 5 mm
    • 5.4.3. 6 mm
    • 5.4.4. 8 mm
    • 5.4.5. 12 mm
  • 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.5.1. Hospital Pharmacy
    • 5.5.2. Retail Pharmacy
    • 5.5.3. Online Pharmacy
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Standard Pen Needles
    • 6.1.2. Safety Pen Needles
  • 6.2. Market Analysis, Insights and Forecast - By Drug Type
    • 6.2.1. Insulin
    • 6.2.2. GLP-1
    • 6.2.3. Growth Hormone
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.3.1. Diabetes
    • 6.3.2. Obesity
    • 6.3.3. Hormone Deficiency
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Needle Size
    • 6.4.1. 4 mm
    • 6.4.2. 5 mm
    • 6.4.3. 6 mm
    • 6.4.4. 8 mm
    • 6.4.5. 12 mm
  • 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.5.1. Hospital Pharmacy
    • 6.5.2. Retail Pharmacy
    • 6.5.3. Online Pharmacy
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Standard Pen Needles
    • 7.1.2. Safety Pen Needles
  • 7.2. Market Analysis, Insights and Forecast - By Drug Type
    • 7.2.1. Insulin
    • 7.2.2. GLP-1
    • 7.2.3. Growth Hormone
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.3.1. Diabetes
    • 7.3.2. Obesity
    • 7.3.3. Hormone Deficiency
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Needle Size
    • 7.4.1. 4 mm
    • 7.4.2. 5 mm
    • 7.4.3. 6 mm
    • 7.4.4. 8 mm
    • 7.4.5. 12 mm
  • 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.5.1. Hospital Pharmacy
    • 7.5.2. Retail Pharmacy
    • 7.5.3. Online Pharmacy
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Standard Pen Needles
    • 8.1.2. Safety Pen Needles
  • 8.2. Market Analysis, Insights and Forecast - By Drug Type
    • 8.2.1. Insulin
    • 8.2.2. GLP-1
    • 8.2.3. Growth Hormone
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.3.1. Diabetes
    • 8.3.2. Obesity
    • 8.3.3. Hormone Deficiency
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Needle Size
    • 8.4.1. 4 mm
    • 8.4.2. 5 mm
    • 8.4.3. 6 mm
    • 8.4.4. 8 mm
    • 8.4.5. 12 mm
  • 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.5.1. Hospital Pharmacy
    • 8.5.2. Retail Pharmacy
    • 8.5.3. Online Pharmacy
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. Australia
    • 8.6.4. India
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Standard Pen Needles
    • 9.1.2. Safety Pen Needles
  • 9.2. Market Analysis, Insights and Forecast - By Drug Type
    • 9.2.1. Insulin
    • 9.2.2. GLP-1
    • 9.2.3. Growth Hormone
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.3.1. Diabetes
    • 9.3.2. Obesity
    • 9.3.3. Hormone Deficiency
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Needle Size
    • 9.4.1. 4 mm
    • 9.4.2. 5 mm
    • 9.4.3. 6 mm
    • 9.4.4. 8 mm
    • 9.4.5. 12 mm
  • 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.5.1. Hospital Pharmacy
    • 9.5.2. Retail Pharmacy
    • 9.5.3. Online Pharmacy
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Pen Needles Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Standard Pen Needles
    • 10.1.2. Safety Pen Needles
  • 10.2. Market Analysis, Insights and Forecast - By Drug Type
    • 10.2.1. Insulin
    • 10.2.2. GLP-1
    • 10.2.3. Growth Hormone
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.3.1. Diabetes
    • 10.3.2. Obesity
    • 10.3.3. Hormone Deficiency
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Needle Size
    • 10.4.1. 4 mm
    • 10.4.2. 5 mm
    • 10.4.3. 6 mm
    • 10.4.4. 8 mm
    • 10.4.5. 12 mm
  • 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.5.1. Hospital Pharmacy
    • 10.5.2. Retail Pharmacy
    • 10.5.3. Online Pharmacy
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
    • 10.6.2. GCC
    • 10.6.3. Rest of Latin America

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Novo Nordisk A/S
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Embecta Corp.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. B. Braun SE
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Owen Mumford
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. BD
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Cardinal Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. SOL-Millennium
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Terumo Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. MTD Medical Technology and Devices S.p.A.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. UltiMed, Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Allison Medical, Inc.
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 2: Global Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 3: Global Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 4: Global Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 5: Global Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 6: Global Pen Needles Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 7: North America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 8: North America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 9: North America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 10: North America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 11: North America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 12: North America Pen Needles Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 13: Europe Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 14: Europe Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 15: Europe Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 16: Europe Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 17: Europe Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 18: Europe Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 19: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 20: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 21: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 22: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 23: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 24: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 25: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 26: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 27: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 28: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 29: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 30: Latin America Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 31: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2019-2032
  • Table 32: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
  • Table 33: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
  • Table 34: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
  • Table 35: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 36: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2032
  • Figure 2: Global Pen Needles Market Value Share (%), by Product Type, 2025 & 2032
  • Figure 3: Global Pen Needles Market Value Share (%), by Drug Type, 2025 & 2032
  • Figure 4: Global Pen Needles Market Value Share (%), by Needle Size, 2025 & 2032
  • Figure 5: Global Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2032
  • Figure 6: Global Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2032
  • Figure 7: Global Pen Needles Market Value (USD billion), by Region, 2025 & 2032
  • Figure 8: North America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 9: North America Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 10: North America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 11: North America Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 12: North America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 13: North America Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 14: North America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 15: North America Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 16: North America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 17: North America Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 18: North America Pen Needles Market Value (USD billion), By Country, 2025 & 2032
  • Figure 19: North America Pen Needles Market Value Share (%), By Country, 2024
  • Figure 20: Europe Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 21: Europe Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 22: Europe Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 23: Europe Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 24: Europe Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 25: Europe Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 26: Europe Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 27: Europe Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 28: Europe Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 29: Europe Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 30: Europe Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 31: Europe Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 32: Asia Pacific Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 33: Asia Pacific Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 34: Asia Pacific Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 35: Asia Pacific Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 36: Asia Pacific Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 37: Asia Pacific Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 38: Asia Pacific Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 39: Asia Pacific Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 40: Asia Pacific Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 41: Asia Pacific Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 42: Asia Pacific Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 43: Asia Pacific Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 44: Latin America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 45: Latin America Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 46: Latin America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 47: Latin America Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 48: Latin America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 49: Latin America Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 50: Latin America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 51: Latin America Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 52: Latin America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 53: Latin America Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 54: Latin America Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 55: Latin America Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 56: Middle East & Africa Pen Needles Market Value (USD billion), by Product Type, 2025 & 2032
  • Figure 57: Middle East & Africa Pen Needles Market Value Share (%), by Product Type, 2024
  • Figure 58: Middle East & Africa Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2032
  • Figure 59: Middle East & Africa Pen Needles Market Value Share (%), by Drug Type, 2024
  • Figure 60: Middle East & Africa Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2032
  • Figure 61: Middle East & Africa Pen Needles Market Value Share (%), by Needle Size, 2024
  • Figure 62: Middle East & Africa Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2032
  • Figure 63: Middle East & Africa Pen Needles Market Value Share (%), by Disease Indication, 2024
  • Figure 64: Middle East & Africa Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2032
  • Figure 65: Middle East & Africa Pen Needles Market Value Share (%), by Distribution Channel, 2024
  • Figure 66: Middle East & Africa Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2032
  • Figure 67: Middle East & Africa Pen Needles Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 68: Global Pen Needles Market Share (%), By Company, 2024